July 05, 2026 10:26 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'Why can't citizens protest against the government? They are being made slaves by slapping cases': Bombay HC slams Mumbai Police, quashes activist's externment | 'First he cheats on me...': Siya Goyal's old pub video goes viral amid probe into fiancé Ketan Agarwal's alleged murder | Ronaldo's goal, Ramos' last-gasp winner send Portugal past Croatia, set up Spain clash | India-US trade deal almost done! Piyush Goyal hints at breakthrough | Ram Mandir donation scam: Champat Rai points finger at his own driver | PM Modi welcomes Japanese PM Sanae Takaichi as India-Japan ties enter a new era | 'Not an isolated incident': India slams Pakistan after 125-year-old historic Gurdwara is demolished | Ram Mandir donation theft: Six accused were employed by Varanasi-based security firm, probe reveals | Ayodhya Ram Temple donation theft: Probe says majority of money was allegedly stolen during Kumbh Mela | Commercial LPG price slashed by Rs 183.50 from July 1; check new rates in Delhi, Mumbai, Kolkata and Chennai
Coronavirus Vaccine
Image Credit: Pixabay

AstraZeneca-Oxford and Pfizer vaccines provide over 80 pc protection against Covid variant first found in India

| @indiablooms | May 23, 2021, at 06:53 am

London/IBNS: Two doses of AstraZeneca vaccine or Pfizer vaccine can give more than 80 per cent protection from the B1.617.2 variant of coronavirus first found in India, a new study conducted by the UK government has revealed, media reports said.

The study is based on the data from Public Health England (PHE), media reports informed.

It also found that the two doses provide 87 per cent protection from B.117 variant first found in Kent region of England and also considered highly transmissible, the reports stated.

The latest PHE data have shown that the infection from B1.617.2 have risen by 2,111 over the past week and now stand at 3,424 cases across the country.

AstraZeneca vaccine is manufactured in India by Serum Institute of India under the name of Covishield.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.